Search
See the whole debate « Previous speaker Next speaker »
Dr. Susan O'Dwyer:
We will follow that up. On generics and biosimilar products, does the IPU get many complaints about bad reactions and so on if patients are changed from the branded medicine?
No comments
Log in or join to post a public comment.
No comments